Related Experiment Video
Updated: May 10, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Left atrial coagulation activity in patient with mitral stenosis in sinus rhythm
Songsak Kiatchoosakun1, Chaiyasith Wongvipaporn, Nantarat Komanasin
1Division of Cardiology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. sonkia@kku.ac.th
Insights
Coagulation activity in mitral stenosis patients is similar in sinus rhythm and atrial fibrillation. This suggests anticoagulation therapy may benefit patients regardless of heart rhythm.
Area of Science:
- Cardiology
- Hematology
- Biochemistry
Background:
- Anticoagulation is recommended for mitral stenosis (MS) with atrial fibrillation (AF).
- Its use in MS patients with sinus rhythm (SR) is debated.
- Understanding coagulation in MS patients with different rhythms is crucial.
Purpose of the Study:
- To compare coagulation activity in MS patients with SR versus AF.
- To evaluate markers of thrombin generation and fibrinolysis.
Main Methods:
- Studied 35 MS patients undergoing percutaneous balloon mitral valvotomy.
- Measured atrial blood levels of thrombin-antithrombin complex, fibrinogen, factor XIII, and D-dimer.
- Compared these markers between patients in SR (n=18) and AF (n=17).
Main Results:
- No significant differences in thrombin-antithrombin complex, fibrinogen, factor XIII, or D-dimer levels were found between MS patients in SR and AF.
- Coagulation marker levels did not correlate with left atrial size.
Conclusions:
- Coagulation activity in the left atrium is comparable in MS patients with SR and AF.
- These findings support considering anticoagulation therapy for MS patients in SR.
Objective:
Anticoagulation therapy is strongly recommended in all patients with mitral stenosis (MS) in atrial fibrillation (AF) but this treatment is controversial in patients in sinus rhythm (SR). The objective of the present study was to investigate the coagulation activity in patients with MS in sinus rhythm compared to those in atrial fibrillation.
Material And Method:
The authors studied the levels of biochemical markers of thrombin generation (thrombin-anti-thrombin [TAT] complex,fibrinogen, and factor XIII) and fibrinolysis (D-dimer) in specimens of blood from the atria in 35 consecutive patients with moderate to severe MS (18 in sinus rhythm and 17 in AF) who underwent percutaneous balloon mitral valvotomy.
Results:
The levels coagulation factors in left atrium in patients with MS in SR and AF were thrombin-anti-thrombin complex = 77.21 +/- 8.87 mg/L vs. 73.48 +/- 7.78 mg/L, p = 0.755, fibrinogen = 356.57 +/- 41.86 mg/L vs. 271.62 +/- 22.47 mg/L, p = 0.089, factor XIII = 139.88 +/- 8.96 mg/L vs. 123.42 +/- 6.24 mg/L, p = 0.152, and D-dimer = 846.14 +/- 137.84 mg/L vs. 693.88 +/- 164.67 mg/L, p = 0.481. Levels of coagulation activities did not correlate with the left atrial size.
Conclusion:
This present study demonstrates that coagulation activity is not different whether they are in SR or in AF and suggests that anticoagulation therapy should be considered in these patients.
More Related Videos
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis I: Introduction
Mitral Stenosis III: Medical Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation III: Medical Management
Mitral Regurgitation I: Introduction

